Riverwater Partners LLC
- SEC CIK
- 0001882572
- Latest filing
- Aug 14, 2026
HBIO holding history
Harvard Bioscience Inc in every 13F filed by Riverwater Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −103,414−100.0% | Sold out | Holders |
| Q3 2024 | 103,414 | $264.7K | 0.1% | −2,563−2.4% | Reduced | Holders |
| Q2 2024 | 105,977 | $302.0K | 0.2% | +12,780+13.7% | Added | Holders |
| Q1 2024 | 93,197 | $395.2K | 0.3% | +11,492+14.1% | Added | Holders |
| Q4 2023 | 81,705 | $437.1K | 0.3% | +223+0.3% | Added | Holders |
| Q3 2023 | 81,482 | $350.4K | 0.3% | +37,171+83.9% | Added | Holders |
| Q2 2023 | 44,311 | $243.3K | 0.2% | −13,008−22.7% | Reduced | Holders |
| Q1 2023 | 57,319 | $240.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 57,319 | $158.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 57,319 | $147.0K | 0.1% | −35,886−38.5% | Reduced | Holders |
| Q2 2022 | 93,205 | $336.0K | 0.3% | +62+0.1% | Added | Holders |
| Q1 2022 | 93,143 | $578.0K | 1.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 93,143 | $657.0K | 0.6% | – | No prior filing | Holders |